ATE440613T1 - Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum - Google Patents

Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum

Info

Publication number
ATE440613T1
ATE440613T1 AT03724331T AT03724331T ATE440613T1 AT E440613 T1 ATE440613 T1 AT E440613T1 AT 03724331 T AT03724331 T AT 03724331T AT 03724331 T AT03724331 T AT 03724331T AT E440613 T1 ATE440613 T1 AT E440613T1
Authority
AT
Austria
Prior art keywords
androgen
regulated
cell growth
cancer cell
inhibiting cancer
Prior art date
Application number
AT03724331T
Other languages
English (en)
Inventor
Shiv Srivastava
Judd Moul
Linda Xu
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Application granted granted Critical
Publication of ATE440613T1 publication Critical patent/ATE440613T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03724331T 2002-05-10 2003-05-09 Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum ATE440613T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37894902P 2002-05-10 2002-05-10
PCT/US2003/013401 WO2003095611A2 (en) 2002-05-10 2003-05-09 Androgen-regulated pmepa1 and cancer

Publications (1)

Publication Number Publication Date
ATE440613T1 true ATE440613T1 (de) 2009-09-15

Family

ID=29420458

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724331T ATE440613T1 (de) 2002-05-10 2003-05-09 Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum

Country Status (7)

Country Link
EP (1) EP1503780B1 (de)
JP (1) JP4744140B2 (de)
AT (1) ATE440613T1 (de)
AU (1) AU2003231196C1 (de)
CA (1) CA2485138C (de)
DE (1) DE60328979D1 (de)
WO (1) WO2003095611A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023097293A2 (en) * 2021-11-23 2023-06-01 President And Fellows Of Harvard College Anti-pmepa-1 antibodies or antigen binding fragments thereof, compositions, and uses thereof
CN114524872A (zh) * 2022-03-09 2022-05-24 广州诺诚生物技术研发有限公司 一种用于乳腺癌检测的单克隆抗体及其试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
ATE168416T1 (de) 1989-10-05 1998-08-15 Optein Inc Zellfreie synthese und isolierung von genen und polypeptiden
US5747334A (en) 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5840507A (en) * 1997-03-19 1998-11-24 Oncotech, Inc. Methods for cancer prognosis and diagnosis
US6268377B1 (en) * 1998-09-28 2001-07-31 Merck & Co., Inc. Method for treating androgen-related conditions
AU2884200A (en) * 1999-02-24 2000-09-14 Trustees Of Tufts College Androgen-induced suppressor of cell proliferation and uses thereof
CA2362924A1 (en) * 1999-03-01 2000-09-08 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
US6566130B1 (en) * 2000-01-28 2003-05-20 Henry M. Jackson Foundation For The Advancement Of Military Medicine Androgen-regulated gene expressed in prostate tissue
EP1474528A4 (de) * 2000-10-13 2006-06-14 Protein Design Labs Inc Methoden zur diagnose von prostatakrebs, zusammensetzungen und methoden zur untersuchung auf prostatakrebs-modulatoren

Also Published As

Publication number Publication date
EP1503780A4 (de) 2006-01-18
JP2006508031A (ja) 2006-03-09
DE60328979D1 (de) 2009-10-08
JP4744140B2 (ja) 2011-08-10
WO2003095611A2 (en) 2003-11-20
AU2003231196C1 (en) 2009-05-21
CA2485138A1 (en) 2003-11-20
AU2003231196A1 (en) 2003-11-11
CA2485138C (en) 2015-04-28
EP1503780B1 (de) 2009-08-26
EP1503780A2 (de) 2005-02-09
AU2003231196B2 (en) 2008-05-01
WO2003095611A3 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
DE60038951D1 (de) Verfahren zur inhibierung von gehirntumorwachstum durch verwendung von antagonisten von integrinen
ATE303445T1 (de) Verfahren zur regulation der transkription von fremden genen in gegenwart von stickstoff
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
IL157756A (en) Methods for assaying activity of trancriptional control elements
ATE513911T1 (de) Verfahren und zusammensetzungen für rna- interferenz
BRPI0403169A (pt) Prognósticos de câncer colorretal
ATE335086T1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
DE60322214D1 (de) "frog-prince" - ein transposonvektor für den gentransfer bei wirbeltieren
DE60236921D1 (de) Verfahren und zusammensetzungen zur verwendung von mhc-klasse ii-invariante-kette-polypeptid als rezeptor für makrophagenwanderung-hemmfaktor
ATE426043T1 (de) Verfahren zur identifizierung des brustkrebsrisikos
Sloutskin et al. The core promoter is a regulatory hub for developmental gene expression
DE60225312D1 (de) Samenspezifische 7s-alpha-promoter zur expression von genen in pflanzen
ATE421574T1 (de) Zellkulturmethode zur erzeugung von prostata- ähnlichen acini
ATE387220T1 (de) Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis
ATE489478T1 (de) Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation
EP2266628A3 (de) Methode zur Bestimmung der Anfälligkeit für Knochenmetastasen über die Expression von EPhA2
ATE440613T1 (de) Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum
PT1529116E (pt) Métodos para o tratamento da demência com base no genótipo da apo e
DE602004032114D1 (de) Rna-interferenz für das gen znfn3a1 als verfahren zur hemmung des wachstums von krebszellen
ATE329055T1 (de) Methode zur erstellung von genexpressionsprofilen
DE60137721D1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
DE10345021A1 (de) Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen
ATE339208T1 (de) Verwendung von progesteronrezeptorhemmern zur behandlung von steroid-resistentem brustkrebs
DE60320302D1 (de) Verfahren zur identifikation von modulatoren des humanen orexin-2-rezeptors
ATE429931T1 (de) Zusammensetzungen zur hemmung der proliferation und infiltration von gehirntumorzellen durch expression der ampa-typ glutamat-rezeptor- untereinheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties